{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:34:21Z","timestamp":1772166861933,"version":"3.50.1"},"reference-count":42,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,1]]},"DOI":"10.1210\/jc.2007-2611","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T23:08:57Z","timestamp":1207091337000},"page":"2390-2401","source":"Crossref","is-referenced-by-count":239,"title":["The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas"],"prefix":"10.1210","volume":"93","author":[{"given":"Chrysanthia A.","family":"Leontiou","sequence":"first","affiliation":[{"name":"Departments of Endocrinology (C.A.L., M.G., F.L., S.H., H.S.C., S.C.J., J.P.M., S.A.A., J.P.C., A.B.G., M.K.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"Maria","family":"Gueorguiev","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (C.A.L., M.G., F.L., S.H., H.S.C., S.C.J., J.P.M., S.A.A., J.P.C., A.B.G., M.K.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"Jacqueline","family":"van der Spuy","sequence":"additional","affiliation":[{"name":"Institute of Ophthalmology (J.v.d.S.), University College London, United Kingdom EC1V 9EL"}]},{"given":"Richard","family":"Quinton","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (R.Q.), Royal Victoria Infirmary and University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, United Kingdom NE1 4LP"}]},{"given":"Francesca","family":"Lolli","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (C.A.L., M.G., F.L., S.H., H.S.C., S.C.J., J.P.M., S.A.A., J.P.C., A.B.G., M.K.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"Sevda","family":"Hassan","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (C.A.L., M.G., F.L., S.H., H.S.C., S.C.J., J.P.M., S.A.A., J.P.C., A.B.G., M.K.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"Harvinder S.","family":"Chahal","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (C.A.L., M.G., F.L., S.H., H.S.C., S.C.J., J.P.M., S.A.A., J.P.C., A.B.G., M.K.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"Susana C.","family":"Igreja","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (C.A.L., M.G., F.L., S.H., H.S.C., S.C.J., J.P.M., S.A.A., J.P.C., A.B.G., M.K.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"Suzanne","family":"Jordan","sequence":"additional","affiliation":[{"name":"Department of Histopathology (S.J., D.M.B.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"Janice","family":"Rowe","sequence":"additional","affiliation":[{"name":"Department of London Research Institute Cancer Research, UK (J.R., G.P.), London, United Kingdom WC2A 3PX"}]},{"given":"Marie","family":"Stolbrink","sequence":"additional","affiliation":[{"name":"Department of Anatomy (M.S., H.C.C.), University of Oxford, Oxford, United Kingdom OX1 3QX"}]},{"given":"Helen C.","family":"Christian","sequence":"additional","affiliation":[{"name":"Department of Anatomy (M.S., H.C.C.), University of Oxford, Oxford, United Kingdom OX1 3QX"}]},{"given":"Jessica","family":"Wray","sequence":"additional","affiliation":[{"name":"Department of William Harvey Research Institute (J.W., D.B.-B.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"David","family":"Bishop-Bailey","sequence":"additional","affiliation":[{"name":"Department of William Harvey Research Institute (J.W., D.B.-B.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"Dan M.","family":"Berney","sequence":"additional","affiliation":[{"name":"Department of Histopathology (S.J., D.M.B.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"John A. H.","family":"Wass","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (J.A.H.W.), Churchill Hospital, Oxford, United Kingdom OX3 7LJ"}]},{"given":"Vera","family":"Popovic","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (V.P.), University Clinical Center, Belgrade, Serbia 11000"}]},{"suffix":"Jr.","given":"Anto\u0302nio","family":"Ribeiro-Oliveira","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (A.R.-O.), Federal University of Minas Gerais, 30330-120 Belo Horizonte, Brazil"}]},{"given":"Monica R.","family":"Gadelha","sequence":"additional","affiliation":[{"name":"Department of Hospital Universita\u0301rio Clementino Fraga Filho (M.R.G.), Universidade Federal do Rio de Janeiro, 21949-590 Rio de Janeiro, Brazil"}]},{"given":"John P.","family":"Monson","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (C.A.L., M.G., F.L., S.H., H.S.C., S.C.J., J.P.M., S.A.A., J.P.C., A.B.G., M.K.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"Scott A.","family":"Akker","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (C.A.L., M.G., F.L., S.H., H.S.C., S.C.J., J.P.M., S.A.A., J.P.C., A.B.G., M.K.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"Julian R. E.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (J.R.E.D.), University of Manchester, Manchester, United Kingdom M13 9PT"}]},{"given":"Richard N.","family":"Clayton","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (R.N.C.), University Hospital of North Staffordshire, Stoke-on-Trent, United Kingdom ST4 6QG"}]},{"given":"Katsuhiko","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmacology (K.Y., T.I.), The University of Tokushima, Tokushima 770-8504 Japan"}]},{"given":"Takeo","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmacology (K.Y., T.I.), The University of Tokushima, Tokushima 770-8504 Japan"}]},{"given":"Akira","family":"Matsuno","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery (A.M.), Teikyo University, Ichihara City, Chiba 299-0111, Japan"}]},{"given":"Kuniki","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery (K.E.), Hiroshima University, Hiroshima 734-8551, Japan"}]},{"given":"Ma\u0302da\u0302lina","family":"Musat","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (M.M.), Carol Davila University of Medicine and Pharmacy, Bucharest, Romania 020021"}]},{"given":"Daniel","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (D.F.), Derriford Hospital, Portsmouth, United Kingdom PL6 8DH"}]},{"given":"Gordon","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of London Research Institute Cancer Research, UK (J.R., G.P.), London, United Kingdom WC2A 3PX"}]},{"given":"Graeme B.","family":"Bolger","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center (G.B.B.), University of Alabama, Birmingham, Alabama 35294"}]},{"given":"J. Paul","family":"Chapple","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (C.A.L., M.G., F.L., S.H., H.S.C., S.C.J., J.P.M., S.A.A., J.P.C., A.B.G., M.K.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"Lawrence A.","family":"Frohman","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (L.A.F.), University of Illinois at Chicago, Chicago, Illinois 60608"}]},{"given":"Ashley B.","family":"Grossman","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (C.A.L., M.G., F.L., S.H., H.S.C., S.C.J., J.P.M., S.A.A., J.P.C., A.B.G., M.K.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]},{"given":"Ma\u0301rta","family":"Korbonits","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (C.A.L., M.G., F.L., S.H., H.S.C., S.C.J., J.P.M., S.A.A., J.P.C., A.B.G., M.K.), Barts and the London School of Medicine, United Kingdom EC1M 6BQ"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114042331200_R1","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly.","volume":"355","author":"Melmed","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114042331200_R2","first-page":"249","article-title":"Loss of heterozygosity on chromosome 11q13 in two families with acromegaly\/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene.","volume":"84","author":"Gadelha","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042331200_R3","first-page":"239","article-title":"Inactivation of the tumor suppressor gene on 11q13 in brothers with familial acrogigantism without multiple endocrine neoplasia type 1.","volume":"82","author":"Yamada","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042331200_R4","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1210\/jc.2005-2671","article-title":"Clinical characterization of familial isolated pituitary adenomas.","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042331200_R5","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1126100","article-title":"Pituitary adenoma predisposition caused by germline mutations in the AIP gene.","volume":"312","author":"Vierimaa","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041114042331200_R6","first-page":"707","article-title":"Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1\u201311q13.3 and evidence for a potential second locus at chromosome 2p16\u201312.","volume":"85","author":"Gadelha","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042331200_R7","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1210\/jc.2005-1478","article-title":"Tumor deletion mapping on chromosome 11q13 in eight families with isolated familial somatotropinoma and in 15 sporadic somatotropinomas.","volume":"90","author":"Soares","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042331200_R8","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1093\/nar\/24.23.4741","article-title":"XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation.","volume":"24","author":"Kuzhandaivelu","year":"1996","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019041114042331200_R9","doi-asserted-by":"crossref","first-page":"11452","DOI":"10.1074\/jbc.272.17.11452","article-title":"Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo.","volume":"272","author":"Carver","year":"1997","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114042331200_R10","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/jc.2006-2513","article-title":"Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.","volume":"92","author":"Daly","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042331200_R11","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1210\/jc.2006-2394","article-title":"Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma.","volume":"92","author":"Toledo","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042331200_R12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2265.2007.02758.x","article-title":"The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.","volume":"66","author":"Iwata","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042331200_R13","doi-asserted-by":"crossref","first-page":"36407","DOI":"10.1074\/jbc.M004236200","article-title":"Binding of aryl hydrocarbon receptor (AhR) to AhR-interacting protein. The role of hsp90.","volume":"275","author":"Bell","year":"2000","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114042331200_R14","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1124\/mol.106.029215","article-title":"Endogenous hepatic expression of the hepatitis B virus X-associated protein 2 is adequate for maximal association with aryl hydrocarbon receptor-90-kDa heat shock protein complexes.","volume":"70","author":"Hollingshead","year":"2006","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t2019041114042331200_R15","doi-asserted-by":"crossref","first-page":"33346","DOI":"10.1074\/jbc.M506619200","article-title":"Redefining the role of the endogenous XAP2 and C-terminal hsp70-interacting protein on the endogenous Ah receptors expressed in mouse and rat cell lines.","volume":"280","author":"Pollenz","year":"2005","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114042331200_R16","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1124\/mol.106.027672","article-title":"Role of endogenous XAP2 protein on the localization and nucleocytoplasmic shuttling of the endogenous mouse Ahb-1 receptor in the presence and absence of ligand.","volume":"70","author":"Pollenz","year":"2006","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t2019041114042331200_R17","doi-asserted-by":"crossref","first-page":"33351","DOI":"10.1074\/jbc.M303269200","article-title":"Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2.","volume":"278","author":"Bolger","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114042331200_R18","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1074\/jbc.M610942200","article-title":"Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor.","volume":"282","author":"de Oliveira","year":"2007","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114042331200_R19","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/sj.embor.7400778","article-title":"The co-chaperone XAP2 is required for activation of hypothalamic thyrotropin-releasing hormone transcription in vivo.","volume":"7","author":"Froidevaux","year":"2006","journal-title":"EMBO Rep"},{"key":"key\n\t\t\t\t2019041114042331200_R20","doi-asserted-by":"crossref","first-page":"24721","DOI":"10.1074\/jbc.M603175200","article-title":"Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein.","volume":"281","author":"Kang","year":"2006","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114042331200_R21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1083\/jcb.200305051","article-title":"AIP is a mitochondrial import mediator that binds to both import receptor Tom20 and preproteins.","volume":"163","author":"Yano","year":"2003","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t2019041114042331200_R22","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1210\/me.2007-0211","article-title":"RELB, a new partner of aryl hydrocarbon receptor-mediated transcription.","volume":"21","author":"Vogel","year":"2007","journal-title":"Mol Endocrinol"},{"key":"key\n\t\t\t\t2019041114042331200_R23","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1210\/jc.2005-0998","article-title":"The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly.","volume":"90","author":"Bhayana","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042331200_R24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1530\/eje.0.1500643","article-title":"A meiotic recombination in a new isolated familial somatotropinoma kindred.","volume":"150","author":"Luccio-Camelo","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114042331200_R25","doi-asserted-by":"crossref","first-page":"45652","DOI":"10.1074\/jbc.M407840200","article-title":"The aryl hydrocarbon (Ah) receptor transcriptional regulator hepatitis B virus X-associated protein 2 antagonizes p23 binding to Ah receptor-Hsp90 complexes and is dispensable for receptor function.","volume":"279","author":"Hollingshead","year":"2004","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114042331200_R26","doi-asserted-by":"crossref","first-page":"37448","DOI":"10.1074\/jbc.M006873200","article-title":"Subcellular localization of the aryl hydrocarbon receptor is modulated by the immunophilin homolog hepatitis B virus X-associated protein 2.","volume":"275","author":"Petrulis","year":"2000","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114042331200_R27","first-page":"640","article-title":"The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers.","volume":"118","author":"Zudaire","year":"2008","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114042331200_R28","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/jc.2006-2702","article-title":"Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.","volume":"92","author":"Barlier","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042331200_R29","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1073\/pnas.0700004104","article-title":"Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.","volume":"104","author":"Georgitsi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041114042331200_R30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.bjc.6603573","article-title":"Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers.","volume":"96","author":"Georgitsi","year":"2007","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2019041114042331200_R31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-07-0181","article-title":"Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.","volume":"157","author":"Cazabat","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114042331200_R32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-07-0533","article-title":"Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene.","volume":"157","author":"Naves","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114042331200_R33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1385\/EP:11:1:41","article-title":"Octreotide effect on growth hormone and somatostatin subtype 2 receptor mRNAs of the human pituitary somatotroph adenomas.","volume":"11","author":"Stefaneanu","year":"2000","journal-title":"Endocr Pathol"},{"key":"key\n\t\t\t\t2019041114042331200_R34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1022193015993","article-title":"Isolated familial somatotropinomas: clinical features and analysis of the MEN1 gene.","volume":"5","author":"De Menis","year":"2002","journal-title":"Pituitary"},{"key":"key\n\t\t\t\t2019041114042331200_R35","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1210\/jc.2005-2347","article-title":"Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage.","volume":"91","author":"Cozzi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042331200_R36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1330451","article-title":"Familial acromegaly: a specific clinical entity\u2014further evidence from the genetic study of a three-generation family.","volume":"133","author":"Benlian","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114042331200_R37","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1677\/ERC-07-0025","article-title":"No evidence of somatic AIP mutations in sporadic endocrine neoplasia","volume":"14","author":"Raitila","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t2019041114042331200_R38","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1210\/jc.2006-1731","article-title":"Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas.","volume":"91","author":"Yu","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042331200_R39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12022-007-0010-z","article-title":"AIP mutations are not identified in patients with sporadic pituitary adenomas.","volume":"18","author":"Digiovanni","year":"2007","journal-title":"Endocr Pathol"},{"key":"key\n\t\t\t\t2019041114042331200_R40","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrc926","article-title":"The pathogenesis of pituitary tumours.","volume":"2","author":"Asa","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t2019041114042331200_R41","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1227\/00006123-199411000-00023","article-title":"Gigantism in sibling unrelated to multiple endocrine neoplasia: case report.","volume":"35","author":"Matsuno","year":"1994","journal-title":"Neurosurgery"},{"key":"key\n\t\t\t\t2019041114042331200_R42","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2265.1990.tb00918.x","article-title":"Familial acromegaly: studies in three families.","volume":"32","author":"McCarthy","year":"1990","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/6\/2390\/9058502\/jcem2390.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T05:01:41Z","timestamp":1708750901000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/6\/2390\/2598982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,1]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-2611","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1118746.574817","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,1]]}}}